Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Nouveau Life Pharmaceuticals, Inc.
BCSC Cease Trade Order
Published Jun 6 2012
3 min read

BCSC Cease Trade Order



Cease Trade Order 

Nouveau Life Pharmaceuticals, Inc. 

Section 164 of the Securities Act, R.S.B.C. 1996, c. 418 

¶ 1 Nouveau Life Pharmaceuticals, Inc. (NOUV) formerly Hybrid Fuels Inc is a Nevada corporation that is an OTC reporting issuer under BC Instrument 51-509 Issuers Quoted on the U.S. Over-the-Counter Markets (BCI 51-509), since September 15, 2008, because its business has been directed or administered in or from British Columbia. 

¶ 2 NOUV has not filed any disclosure documents on SEDAR as required by BCI 51-509 (the required records). 

¶ 3 Under section 164(1) of the Act, the Executive Director orders that trading in the securities of NOUV cease until: 

1. NOUV files the required records completed in accordance with the Act and regulations, and 

2. The Executive Director makes an order under section 164 of the Act revoking this order. 

¶ 4 June 6, 2012 



John Porges 
Manager 
Corporate Finance